This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lemoine, N., Jain, S., Silvestre, F. et al. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer. Br J Cancer 64, 79–83 (1991). https://doi.org/10.1038/bjc.1991.243
Issue Date:
DOI: https://doi.org/10.1038/bjc.1991.243
This article is cited by
-
HER2 gene (ERBB2)Â amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma
Virchows Archiv (2020)
-
Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study
BMC Cancer (2019)
-
ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
Biological Research (2019)
-
Aptamer-modified Magnetic Nanosensitizer for in vivo MR imaging of HER2-expressing Cancer
Nanoscale Research Letters (2018)
-
Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition
Scientific Reports (2016)